The Multidisciplinary Association for Psychedelic Studies (MAPS) is a nonprofit research and educational organization, which has been conducting research on using MDMA in conjunction with psychotherapy for treating some of the most difficult cases of Post Traumatic Stress Disorder. Although this research is only in its first stages, researchers have already found a high treatment success rate, lower dropout rates, and lower rates of patients receding to previous conditions then compared to traditional therapy with or without SSRIs. Even though these studies are making great headway in the scientific community, governments around the world refuse to regulate MDMA for medicinal use and thus treatment of this type has remained only in clinical trials. We believe that MDMA is much more effective than traditional medicine at curing patients with mental conditions and by summarizing research, interviewing researchers, and creating an easy to understand graphical presentation we hope to inform people of the benefits of MDMA assisted psychotherapy.
If you’d like help further research, MAPS is always looking for donations. You can read more at www.maps.org.
Special thanks to Marcela Ot’Alora for an inside look on her research.
Created by: Brendan Storiz & Adam Gossett
Kai Engel – Moonlight Reprise
Dexter Brian – Seeing the Future
Jon Luc Hefferman – Ascent
The Lovely Moon – Mystery
Chris Zabriskie – Cylinder One
Ecstasy drug therapy – TechKnow
What It Feels Like To Have PTSD
BuzzFeedVideo. What PTSD Is Really Like.
CNN. Patient Talks about Ecstasy Treatment for PTSD
Sanjay Gupta MD: Could Acid, Ecstasy Help PTSD Patients?.
“Erowid MDMA (Ecstasy) Vault : Does MDMA Cause Brain Damage?, by Matthew Baggott & John Mendelson.”
The Great Alexander Shulgin Talks About MDMA-(Ecstasy)
“MAPS: MDMA Pages.”
Ronald Reagan-Speech to the Nation on the Campaign Against Drug Abuse (September 14, 1986)
MDMA The Movie. MDMA The Movie – Sneak Preview.
MDMA Therapy and Healing. Accessed April 29, 2017.
Mithoefer, M. “MDMA Facilitated Treatment of PTSD.” European Neuropsychopharmacology 17 (October 2007): S216. doi:10.1016/S0924-977X(07)70279-1.
Mithoefer, Michael C, Mark T Wagner, Ann T Mithoefer, Lisa Jerome, and Rick Doblin. “The Safety and Efficacy of ±3,4Methylenedioxymethamphetamine-Assisted Psychotherapy in Subjectswith Chronic, Treatment-Resistant Posttraumatic Stress Disorder: The First Randomized Controlled Pilot Study.” Journal of Psychopharmacology 25, no. 4 (April 1, 2011): 439–52. doi:10.1177/0269881110378371.
Oehen, Peter, Rafael Traber, Verena Widmer, and Ulrich Schnyder. “A Randomized, Controlled Pilot Study of MDMA (±3,4-Methylenedioxymethamphetamine)-Assisted Psychotherapy for Treatment of Resistant, Chronic Post-Traumatic Stress Disorder (PTSD).” Journal of Psychopharmacology 27, no. 1 (January 1, 2013): 40–52. doi:10.1177/0269881112464827.
O’shea, Esther, Laura Orio, Isabel Escobedo, Veronica Sanchez, Jorge Camarero, Alfred Richard Green, and Maria Isabel Colado. “MDMA-Induced Neurotoxicity: Long-Term Effects on 5-HT Biosynthesis and the Influence of Ambient Temperature.” British Journal of Pharmacology 148, no. 6 (July 2006): 778–85. doi:10.1038/sj.bjp.0706783.
Passie, Torsten, and Udo Benzenhöfer. “The History of MDMA as an Underground Drug in the United States, 1960–1979.” Journal of Psychoactive Drugs 48, no. 2 (March 14, 2016): 67–75. doi:10.1080/02791072.2015.1128580.
Philipps, Dave. “F.D.A. Agrees to New Trials for Ecstasy as Relief for PTSD Patients.” The New York Times, November 29, 2016.
“PTSD Statistics | PTSD United.” Accessed April 29, 2017.
ReasonTV. MDMA for PTSD: How Ecstasy Is Helping People with Post-Traumatic Stress Disorder. Accessed April 29, 2017.
Sessa, Ben. “MDMA and PTSD Treatment.” Elsevier Ireland Ltd., July 1, 2016. doi:10.1016/j.neulet.2016.07.004.
The Doctors. See an MDMA-Assisted Therapy Session
The Verge. Ecstatic States: Treating PTSD with MDMA.